Researchers at ETH Zurich recently explained the role of a molecular complex that orchestrates the production of proteins in ...

Corrales, a recent biological sciences Ph.D. graduate from the University of Rhode Island, and his advisor, Associate ...

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Gold rarely makes headlines for how it moves. Markets track prices, not pathways. Once refined, metal tends to lose its story. Where it came from, ...

December 24, 2025 / SMX's valuation story has quietly crossed a critical threshold. The company is no longer asking the ...

Once technology is validated and network effects begin to take hold, the next question investors should ask is simple: how efficiently can this platform scale? This is where SMX's valuation profile ...

SMX's valuation story is one that the markets are finally coming to understand: monetization. Not revenue in the narrow, ...

For years, ETH researchers have been investigating a molecular complex that plays a key role in protein synthesis. They have ...

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / In early-stage companies, partnerships are often treated as marketing events. Logos get added to slides. Press releases get circulated. Little ...

One of the most misunderstood aspects of SMX's (NASDAQ:SMX) valuation is the nature of the problem it is addressing. This is not a feature layered onto existing systems, and it is not a workflow ...

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Once industrial validation is achieved, the next inflection point is not linear growth. It is compounding leverage. This is where SMX’s (NASDAQ:SMX ...

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / At its core, the SMX value proposition is not fragmented, even though it touches multiple industries. It is unified. What appears on the surface as ...

A single missing molecule in the brain is emerging as a powerful new clue to why learning and memory are altered in Down ...